Marilena D'Aurelio, PhD

Highlights

1
EMBO molecular medicine · 2023
GMGiovanni Manfredi QCQiuying Chen MDMarilena D'Aurelio
PMID: 37222423PMCID: PMC10331581DOISenior author9 citations

34

4 grants

PI
Modulating ER stress-induced lipotoxicity to ameliorate mitochondrial myopathy
Muscular Dystrophy Associations of America, Inc. · 2026–2029
MDAAA 1454620
MPI
Modulating ER stress-induced lipotoxicity to ameliorate mitochondrial myopathy
National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2026–2028
R21AR087068-01
MPI
Targeting GDF15-GFRAL signaling in mitochondrial myopathies
National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2025–2027
R21AR085715-02
MPI
Metabolic remodeling of skeletal muscle in mitochondrial myopathies
National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2020–2026
R01AR076029-05

Completed grants (6)

MPI
Modulation Of Intermediate Metabolism, A New Therapeutic Approach For Mitochondrial Encephalomyopathies
National Institute of Neurological Disorders and Stroke · 2021–2023
R21NS118233-01A1
Co-I
Estrogen Receptor Beta and Mitochondrial Permeability Transition in Ca2+-Induced Neuronal Injury
National Institute of Neurological Disorders and Stroke · 2016–2022
R01NS095692-01A1
Co-I
Metabolic Profiling of Sporadic ALS Patients: From Fibroblasts to Neurons and Back
National Institute of Neurological Disorders and Stroke · 2015–2020
R01NS093872-04
PI
Intermediary Metabolism Biomarkers in Mitochondrial Myopathies
Muscular Dystrophy Associations of America, Inc. · 2016–2019
MDA418039
KP
Impaired Amino Acid Metabolism in Mitochondrial Diseases
National Institute of Neurological Disorders and Stroke · 2013–2016
R21NS084524-02EWO
KP
Defects of Mitochondrial Dynamics in ALS
National Institute of Neurological Disorders and Stroke · 2009–2014
R01NS062055-01A1